427 filings
Page 4 of 22
6-K
sh8zxjrcaxyrf27cjux
24 Jun 20
Sinovac Receives Approval from China for its Quadrivalent Influenza Vaccine
4:39pm
6-K
i0iv9hpif9i8jbuoq gj
15 Jun 20
Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19
7:18am
6-K
vzls7d88 ye3jxmwiqo
11 Jun 20
Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III
9:16am
6-K
6jc4ohm1ov x2jlz5sp
22 May 20
Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development
8:46am
6-K
vn0w3mq
18 May 20
Current report (foreign)
4:02pm
6-K
9attk83x19ib
6 May 20
Sinovac Announces First Animal Study Results of Vaccine Against COVID-19
10:52am
6-K
2hqh3w1iw3mlilh65 r5
30 Apr 20
Sinovac Reports Unaudited Fourth Quarter 2019 Financial Results and Files 2019 Annual Report on Form 20-F
4:44pm
6-K
0qlgw
17 Apr 20
Sinovac Announces Commencement of Phase I Human Clinical Trial for Vaccine Candidate Against COVID-19
8:39am
6-K
ddju1sk1j6
14 Apr 20
Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-19
4:20pm
8-A12B/A
ulim50
21 Feb 20
Registration of securities on exchange (amended)
4:29pm
6-K
ywo99l5oqw
21 Feb 20
Current report (foreign)
4:24pm
6-K
wtm3n607bbkk
30 Dec 19
Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster
8:44pm
6-K
tt6ufqclvv716ftne1ds
18 Nov 19
Sinovac Reports Unaudited Third Quarter 2019 Financial Results
8:13am
6-K
tgx4r4t9
16 Aug 19
Sinovac Reports Unaudited Second Quarter 2019 Financial Results
6:04am
6-K
9efb hn9pf3
11 Jul 19
Sinovac Reports Unaudited First Quarter 2019 Financial Results
6:10am
6-K
sq3qwwl1vsmgc98f4
30 Apr 19
Sinovac Reports Unaudited Second Half of 2018 Financial Results and Files 2018 Annual Report on Form 20-F
10:51am
6-K
yu0mi
16 Apr 19
Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based
9:53am
6-K
tvdtvlsn0f
15 Apr 19
Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares
6:08am